These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 6102439)

  • 1. Tardive Dyskinesia: Spotlight on Current Approaches to Treatment.
    Debrey SM; Goldsmith DR
    Focus (Am Psychiatr Publ); 2021 Jan; 19(1):14-23. PubMed ID: 34483762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Tardive Syndrome: Medications and Surgical Treatments.
    Factor SA
    Neurotherapeutics; 2020 Oct; 17(4):1694-1712. PubMed ID: 32720245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia: therapeutic options for an increasingly common disorder.
    Cloud LJ; Zutshi D; Factor SA
    Neurotherapeutics; 2014 Jan; 11(1):166-76. PubMed ID: 24310603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous benztropine and propranolol challenges in tardive akathisia.
    Sachdev P; Loneragan C
    Psychopharmacology (Berl); 1993; 113(1):119-22. PubMed ID: 7862817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of propranolol in treating tardive dyskinesia.
    Einarson TR
    Can Med Assoc J; 1981 May; 124(10):1260, 1262. PubMed ID: 7237311
    [No Abstract]   [Full Text] [Related]  

  • 6. Brief report: effects of propranolol in Tourette syndrome.
    Sverd J; Cohen S; Camp JA
    J Autism Dev Disord; 1983 Jun; 13(2):207-13. PubMed ID: 6345501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neuroleptic concentrations and tardive dyskinesia.
    Jeste DV; Linnoila M; Wagner RL; Wyatt RJ
    Psychopharmacology (Berl); 1982; 76(4):377-80. PubMed ID: 6126895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of beta-blocking drugs in psychiatry and neurology.
    Tyrer PJ
    Drugs; 1980 Oct; 20(4):300-8. PubMed ID: 6106546
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tardive dyskinesia: etiology, clinical features and therapy].
    Furer V; Lichtenberg P; Heresco-Levy U
    Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354
    [No Abstract]   [Full Text] [Related]  

  • 10. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR
    Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose propranolol in tardive dyskinesia.
    Bacher NM; Lewis HA
    Am J Psychiatry; 1980 Apr; 137(4):495-7. PubMed ID: 6102439
    [No Abstract]   [Full Text] [Related]  

  • 12. Propranolol in the treatment of tardive dyskinesia.
    Perényi A; Farkas A
    Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627
    [No Abstract]   [Full Text] [Related]  

  • 13. [Improvement of tardive dyskinesia with high doses of propranolol].
    Moreira MJ; Karniol IG
    Rev Paul Med; 1979; 93(3-4):76-8. PubMed ID: 40299
    [No Abstract]   [Full Text] [Related]  

  • 14. Propranolol, anxiety, and tardive dyskinesia.
    Bacher NA; Lewis HA
    J Clin Psychiatry; 1983 May; 44(5):196. PubMed ID: 6133849
    [No Abstract]   [Full Text] [Related]  

  • 15. Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms.
    Wilbur R; Kulik FA
    Prog Neuropsychopharmacol; 1980; 4(6):627-32. PubMed ID: 6111820
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.